Subcutaneous Epcoritamab in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma: Preliminary Phase 1/2 Results
Linton, K. M. Wahlin, B. Leppa, S. Morschhauser, F. Elliott, B. Liu, T. Stirner, M. C. Abbas, A. Falchi, L.
Linton, K. M.
Wahlin, B.
Leppa, S.
Morschhauser, F.
Elliott, B.
Liu, T.
Stirner, M. C.
Abbas, A.
Falchi, L.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Linton KM, Wahlin B, Leppa S, Morschhauser F, Elliott B, Liu T, et al. Subcutaneous Epcoritamab in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma: Preliminary Phase 1/2 Results. British Journal of Haematology. 2022;197:94-.